Brianna Gerber's most recent trade in Niagen Bioscience Inc. was a trade of 213,886 Employee Stock Options (right to buy) done . Disclosure was reported to the exchange on Feb. 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Niagen Bioscience Inc. | Brianna Gerber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 213,886 | 213,886 | - | - | Employee Stock Options (right to buy) | |
| Niagen Bioscience Inc. | Brianna Gerber | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.41 per share. | 01 Dec 2023 | 5,000 | 27,436 (0%) | 0% | 1.4 | 7,050 | Common Stock |
| Niagen Bioscience Inc. | Brianna Gerber | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2023 | 22,436 | 44,872 | - | - | Restricted Stock Unit | |
| Niagen Bioscience Inc. | Brianna Gerber | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2023 | 22,436 | 22,436 (0%) | 0% | - | Common Stock | |
| Niagen Bioscience Inc. | Brianna Gerber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 163,996 | 163,996 | - | - | Employee Stock Options (right to buy) | |
| Niagen Bioscience Inc. | Brianna Gerber | SVP Finance / Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2022 | 100,460 | 100,460 | - | - | Employee Stock Options (right to buy) | |
| Niagen Bioscience Inc. | Brianna Gerber | SVP Finance / Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2022 | 67,308 | 67,308 | - | - | Restricted Stock Unit |